Felbinac
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| biphenyl-4-ylacetic acid | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | P (UK) |
| Routes | Topical |
| Identifiers | |
| CAS number | 5728-52-9 |
| ATC code | M02AA08 |
| PubChem | CID 3332 |
| DrugBank | DB07477 |
| ChemSpider | 3215 |
| UNII | 94WNJ5U8L7 |
| KEGG | D01675 |
| ChEBI | CHEBI:31597 |
| ChEMBL | CHEMBL413965 |
| Chemical data | |
| Formula | C14H12O2 |
| Mol. mass | 212.244 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Felbinac (INN) (or biphenylylacetic acid) is a topical medicine, belonging to the family of medicines known as non-steroidal anti-inflammatory drugs (NSAIDs) of the arylpropionic acid class, which is used to treat muscle inflammation and arthritis. It is an active metabolite of fenbufen.[1]
[edit] Footnotes
[edit] References
- The Merck Index, 12th Edition. 3989
- Description of Felbinac on Tiscali [1]
| This medical article is a stub. You can help Wikipedia by expanding it. |
|
||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||